Study to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Participants With Locally Advanced or Metastatic Solid Tumors
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Locally Advanced or Metastatic Solid Tumors
Interventions: DRUG: Pamiparib|DRUG: Temozolomide
Sponsor: BeiGene
Collaborators: Myriad Genetics, Inc.